Akoya (AKYA) Reports Q1 Loss of $3.54/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- S&P 500 inches lower as Middle East tensions outweigh tech gains
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
Akoya Reports First Quarter 2021 Financial Results and Issues Full Year 2021 Guidance
May 18, 2021 4:05 PM EDTMARLBOROUGH, Mass., May 18, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (Akoya), The Spatial Biology Company®, today announced its financial results for the first quarter ending March 31, 2021.
First Quarter Financial Highlights:
Total revenue for the first quarter of 2021 was $12.2 million, at the high end of the previously provided range of $12.0 million to $12.2 million.Solid quarter of instrument sales, especially CODEX with 20 units sold: 28% increase in total company installed base over the last 12... More